Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-21 10:12 am Purchase |
2024-05-21 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
BML Investment Partners, L.P. | 369,296 11.000% |
199,873 (+117.97%) |
Filing History |
| 2024-05-08 4:33 pm Unchanged |
2024-05-07 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
New Enterprise Associates 15 L.P. | 478,549 14.300% |
0 (Unchanged) |
Filing History |
| 2024-02-05 4:01 pm Purchase |
2023-12-31 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
Octagon Capital Advisors LP | 225,000 6.750% |
225,000 (New Position) |
Filing History |
| 2024-01-16 5:54 pm Purchase |
2024-01-10 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
BML Investment Partners, L.P. | 169,423 5.100% |
169,423 (New Position) |
Filing History |
| 2023-12-26 5:00 pm Purchase |
2023-11-14 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
TANG CAPITAL PARTNERS LP | 333,000 9.996% |
333,000 (New Position) |
Filing History |
| 2023-12-15 4:55 pm Sale |
2023-12-14 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 0 0.000% |
-343,038 (Position Closed) |
Filing History |
| 2023-05-30 4:52 pm Purchase |
2023-05-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
RiverVest Venture Fund III, L.P. | 253,422 7.530% |
12,500 (+5.19%) |
Filing History |
| 2023-05-15 5:16 pm Unchanged |
2023-05-09 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 343,038 10.200% |
0 (Unchanged) |
Filing History |
| 2023-05-09 4:31 pm Purchase |
2023-05-02 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Carlyle Group Inc. CG |
273,046 8.200% |
64,250 (+30.77%) |
Filing History |
| 2022-09-30 4:45 pm Unchanged |
2022-09-27 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 343,038 14.000% |
0 (Unchanged) |
Filing History |
| 2022-08-11 4:52 pm Purchase |
2022-08-01 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Carlyle Group Inc. CG |
208,796 8.500% |
208,796 (New Position) |
Filing History |
| 2022-01-27 3:31 pm Unchanged |
2022-01-20 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 343,038 14.000% |
0 (Unchanged) |
Filing History |
| 2022-01-26 4:10 pm Purchase |
2021-12-31 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
Lundbeckfond Invest A/S | 203,122 8.300% |
203,122 (New Position) |
Filing History |
| 2021-04-23 08:46 am Purchase |
2021-04-13 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
New Enterprise Associates 15 L.P. | 478,549 19.800% |
478,549 (New Position) |
Filing History |
| 2021-04-20 4:07 pm Purchase |
2021-04-13 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Abingworth LLP | 185,823 7.700% |
185,823 (New Position) |
Filing History |
| 2021-04-19 2:04 pm Purchase |
2021-04-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
RiverVest Venture Fund III, L.P. | 240,922 10.000% |
240,922 (New Position) |
Filing History |
| 2021-04-14 4:43 pm Purchase |
2021-04-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 343,038 14.200% |
343,038 (New Position) |
Filing History |